Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa

Laith Aburaddad, Amalia S. Magaret, Connie Celum, Anna Wald, Ira M. Longini, Steven G. Self, Lawrence Corey

Research output: Contribution to journalArticle

175 Citations (Scopus)

Abstract

Background: Extensive evidence from observational studies suggests a role for genital herpes in the HIV epidemic. A number of herpes vaccines are under development and several trials of the efficacy of HSV-2 treatment with acyclovir in reducing HIV acquisition, transmission, and disease progression have just reported their results or will report their results in the next year. The potential impact of these interventions requires a quantitative assessment of the magnitude of the synergy between HIV and HSV-2 at the population level. Methods and Findings: A deterministic compartmental model of HIV and HSV-2 dynamic and interactions was constructed. The nature of the epidemiologic synergy was explored qualitatively and quantitatively compared to other sexually transmitted infections (STIs). The results suggest a more substanial role for HSV-2 in fueling HIV spread in sub-Saharan Africa than other STIs. We estimate that in settings of high HSV-2 prevalence, such as Kisumu, Kenya more than a quarter of incident HIV infections may have been attributed directly to HSV-2. HSV-2 has also contributed considerably to the onward transmission of HIV by increasing the pool of HIV positive persons in the population and may explain one-third of the differential HIV prevalence among the cities of the Four City study. Conversely, we estimate that HIV had only a small net impact on HSV-2 prevalence. Conclusions: HSV-2 role as a biological cofactor in HIV acquisition and transmission may have contributed substantially to HIV particularly by facilitating HIV spread among the low-risk population with stable long-term sexual partnerships. This finding suggests that prevention of HSV-2 infection through a prophylactic vaccine may be an effective intervention both in nascent epidemics with high HIV incidence in the high risk groups, and in established epidemics where a large portion of HIV transmission occurs in stable partnerships.

Original languageEnglish
Article numbere2230
JournalPLoS One
Volume3
Issue number5
DOIs
Publication statusPublished - 21 May 2008
Externally publishedYes

Fingerprint

sexually transmitted diseases
Herpes Genitalis
Sexually Transmitted Diseases
Human Herpesvirus 2
genitalia
HIV
vaccines
Vaccines
risk groups
HIV infections
observational studies
Sub-Saharan Africa
disease course
Kenya
Fueling
Acyclovir
incidence
HIV-2
infection
Africa South of the Sahara

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa. / Aburaddad, Laith; Magaret, Amalia S.; Celum, Connie; Wald, Anna; Longini, Ira M.; Self, Steven G.; Corey, Lawrence.

In: PLoS One, Vol. 3, No. 5, e2230, 21.05.2008.

Research output: Contribution to journalArticle

Aburaddad, Laith ; Magaret, Amalia S. ; Celum, Connie ; Wald, Anna ; Longini, Ira M. ; Self, Steven G. ; Corey, Lawrence. / Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa. In: PLoS One. 2008 ; Vol. 3, No. 5.
@article{57b2be05cb204cbf8420f170c54ef641,
title = "Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa",
abstract = "Background: Extensive evidence from observational studies suggests a role for genital herpes in the HIV epidemic. A number of herpes vaccines are under development and several trials of the efficacy of HSV-2 treatment with acyclovir in reducing HIV acquisition, transmission, and disease progression have just reported their results or will report their results in the next year. The potential impact of these interventions requires a quantitative assessment of the magnitude of the synergy between HIV and HSV-2 at the population level. Methods and Findings: A deterministic compartmental model of HIV and HSV-2 dynamic and interactions was constructed. The nature of the epidemiologic synergy was explored qualitatively and quantitatively compared to other sexually transmitted infections (STIs). The results suggest a more substanial role for HSV-2 in fueling HIV spread in sub-Saharan Africa than other STIs. We estimate that in settings of high HSV-2 prevalence, such as Kisumu, Kenya more than a quarter of incident HIV infections may have been attributed directly to HSV-2. HSV-2 has also contributed considerably to the onward transmission of HIV by increasing the pool of HIV positive persons in the population and may explain one-third of the differential HIV prevalence among the cities of the Four City study. Conversely, we estimate that HIV had only a small net impact on HSV-2 prevalence. Conclusions: HSV-2 role as a biological cofactor in HIV acquisition and transmission may have contributed substantially to HIV particularly by facilitating HIV spread among the low-risk population with stable long-term sexual partnerships. This finding suggests that prevention of HSV-2 infection through a prophylactic vaccine may be an effective intervention both in nascent epidemics with high HIV incidence in the high risk groups, and in established epidemics where a large portion of HIV transmission occurs in stable partnerships.",
author = "Laith Aburaddad and Magaret, {Amalia S.} and Connie Celum and Anna Wald and Longini, {Ira M.} and Self, {Steven G.} and Lawrence Corey",
year = "2008",
month = "5",
day = "21",
doi = "10.1371/journal.pone.0002230",
language = "English",
volume = "3",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "5",

}

TY - JOUR

T1 - Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa

AU - Aburaddad, Laith

AU - Magaret, Amalia S.

AU - Celum, Connie

AU - Wald, Anna

AU - Longini, Ira M.

AU - Self, Steven G.

AU - Corey, Lawrence

PY - 2008/5/21

Y1 - 2008/5/21

N2 - Background: Extensive evidence from observational studies suggests a role for genital herpes in the HIV epidemic. A number of herpes vaccines are under development and several trials of the efficacy of HSV-2 treatment with acyclovir in reducing HIV acquisition, transmission, and disease progression have just reported their results or will report their results in the next year. The potential impact of these interventions requires a quantitative assessment of the magnitude of the synergy between HIV and HSV-2 at the population level. Methods and Findings: A deterministic compartmental model of HIV and HSV-2 dynamic and interactions was constructed. The nature of the epidemiologic synergy was explored qualitatively and quantitatively compared to other sexually transmitted infections (STIs). The results suggest a more substanial role for HSV-2 in fueling HIV spread in sub-Saharan Africa than other STIs. We estimate that in settings of high HSV-2 prevalence, such as Kisumu, Kenya more than a quarter of incident HIV infections may have been attributed directly to HSV-2. HSV-2 has also contributed considerably to the onward transmission of HIV by increasing the pool of HIV positive persons in the population and may explain one-third of the differential HIV prevalence among the cities of the Four City study. Conversely, we estimate that HIV had only a small net impact on HSV-2 prevalence. Conclusions: HSV-2 role as a biological cofactor in HIV acquisition and transmission may have contributed substantially to HIV particularly by facilitating HIV spread among the low-risk population with stable long-term sexual partnerships. This finding suggests that prevention of HSV-2 infection through a prophylactic vaccine may be an effective intervention both in nascent epidemics with high HIV incidence in the high risk groups, and in established epidemics where a large portion of HIV transmission occurs in stable partnerships.

AB - Background: Extensive evidence from observational studies suggests a role for genital herpes in the HIV epidemic. A number of herpes vaccines are under development and several trials of the efficacy of HSV-2 treatment with acyclovir in reducing HIV acquisition, transmission, and disease progression have just reported their results or will report their results in the next year. The potential impact of these interventions requires a quantitative assessment of the magnitude of the synergy between HIV and HSV-2 at the population level. Methods and Findings: A deterministic compartmental model of HIV and HSV-2 dynamic and interactions was constructed. The nature of the epidemiologic synergy was explored qualitatively and quantitatively compared to other sexually transmitted infections (STIs). The results suggest a more substanial role for HSV-2 in fueling HIV spread in sub-Saharan Africa than other STIs. We estimate that in settings of high HSV-2 prevalence, such as Kisumu, Kenya more than a quarter of incident HIV infections may have been attributed directly to HSV-2. HSV-2 has also contributed considerably to the onward transmission of HIV by increasing the pool of HIV positive persons in the population and may explain one-third of the differential HIV prevalence among the cities of the Four City study. Conversely, we estimate that HIV had only a small net impact on HSV-2 prevalence. Conclusions: HSV-2 role as a biological cofactor in HIV acquisition and transmission may have contributed substantially to HIV particularly by facilitating HIV spread among the low-risk population with stable long-term sexual partnerships. This finding suggests that prevention of HSV-2 infection through a prophylactic vaccine may be an effective intervention both in nascent epidemics with high HIV incidence in the high risk groups, and in established epidemics where a large portion of HIV transmission occurs in stable partnerships.

UR - http://www.scopus.com/inward/record.url?scp=48449099125&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48449099125&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0002230

DO - 10.1371/journal.pone.0002230

M3 - Article

VL - 3

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 5

M1 - e2230

ER -